Elevation of plasmatic endothelin in patients with heart failure

Archives of Medical Research

Volumn 34, Issue 5, 2003, Pages 367-372

  Galindo Fraga, Arturo ^a   Arrieta, Oscar ^a   Castillo Martínez, Lilia ^a   Narváez, René ^a   Oseguera Moguel, Jorge ^a   Orea Tejeda, Arturo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Echocardiography; Endothelin; Heart failure; New York Heart Association

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; ENDOTHELIN; TROPONIN T; TUMOR NECROSIS FACTOR; ENDOTHELIN 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; HUMAN; MALE; PARAMETER; RADIOIMMUNOASSAY; SYMPTOMATOLOGY; BLOOD; CLASSIFICATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICS;

ADULT; AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; STATISTICS;

EID: 1542604459     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(03)00071-7     Document Type: Article

References (28)

1. Ellahham S.M., Charlon V., Abassi Z., Calis K. Bosantan and the endothelin system in congestive heart failure. Clin Cardiol. 23:2000;803-807.
2. Grady K.L., Dracup K., Kennedy G., Moser D.K., Piano M., Stevenson L.W., Young J.B. Team management of patients with heart failure. Circulation. 102:2000;2443-2456.
3. Starling R.C. The heart failure pandemic: changing patterns, costs, and treatment strategies. Cleve Clin J Med. 65:1998;351-358.
4. Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation. 102:2000;IV14-IV23.
5. Joseph J., Gilbert E.M. The sympathetic nervous system in chronic heart failure. Prog Card Dis. 41:(Suppl 1):1998;9-16.
6. Cohn J. Is there a role for endothelin in the natural history of heart failure? Circulation. 94:1996;604-606.
7. Lüscher T.F., Barton M. Endothelins and endothelin receptor antagonist. Therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 102:2000;2434-2440.
8. Levin E.R. Endothelins. N Engl J Med. 333:1995;356-363.
9. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature. 415:2002;206-212.
10. Howard P.G., Plumpton C., Davenport A.P. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens. 10:1992;1379-1386.
11. Cowburn P.J., Cleland J.G.F. Endothelin antagonists for chronic heart failure: do they have a role? Eur Heart J. 22:2001;1772-1784.
12. Sharma R., Coats A.J., Anker S.D. The role of inflammatory mediators in chronic heart failure: cytokine, nitric oxide and endothelin-1. Int J Cardiol. 72:2000;175-186.
13. MERITH-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-hf). Lancet. 353:1999;2001-2007.
14. Weber K.T. Aldosterone in congestive heart failure. N Engl J Med. 345:2001;1689-1697.
15. Bolger A.P., Sharma R., Li W., Leenarts M., Kalra P.R., Kemp M., Coats A.J.S., Anker S.D., Gatzoulis M.A. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 106:2002;92-99.
16. Hosokawa A., Nagayama T., Yoshida M., Suzuki-Kusaba M., Hisa H., Kimura T., Satoh S. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs. Eur J Pharmacol. 397:2000;55-61.
17. Ergul S., Parish D.C., Puett D., Ergul A. Racial differences in plasma endothelin-1 concentration in individuals with essential hypertension. Hypertension. 28:1996;652-655.
18. Koyama H., Tabata T., Nishzawa Y., Inoue T., Morii H., Yamaji T. Plasma endothelin levels in patients with uremia. Lancet. 1:1989;991-992.
19. Erbas T., Kabakci G., Koray Z. Plasma big endothelin levels, cardiac autonomic neuropathy and cardiac function in patients with insulin dependent diabetes mellitus. Clin Cardiol. 23:2000;259-263.
20. McMurray J.J., Ray S.G., Abdullah I., Dargie H.J., Morton J.J. Plasma endothelin in chronic heart failure. Circulation. 85:1992;1374-1379.
21. Iwanaga Y., Kihara Y., Hasegawa K., Inagaki K. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricular during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 98:1998;2065-2073.
22. Moser L., Faulhaber J., Wiesner R.J., Ehmke H. Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle. Am J Physiol Regul Integr Comp Physiol. 282:2002;R1389-R1394.
23. Wei C.M., Lerman A., Rodeheffer R.J., McGregor C.G.A., Brandt R.R. Endothelin in human congestive heart failure. Circulation. 89:1994;1580-1586.
24. Hiroe M., Hirata Y., Fujita N., Umezawa S. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol. 68:1991;1114-1115.
25. Packer M. Multicenter, double-blind, placebo-controlled study of long term endothelin blockade with bosentan in chronic heart failure - results of the REACH-1 Trial. (abstract) Circulation. 98:(Suppl):1998;1-3.
26. Krum H. New and emerging pharmacologic strategies in the management of chronic heart failure. Clin Cardiol. 23:2000;724-730.
27. Love M.P., McMurray J.J.V. Endothelin in heart failure: a promising therapeutic target. Heart. 77:1997;93-94.
28. A receptor blockade trial (HEAT). Circulation. 106:2002;2666-2672.